Results 11 to 20 of about 5,469,182 (343)

The hypotensive effect of salt substitutes in stage 2 hypertension: a systematic review and meta-analysis [PDF]

BMC Cardiovascular Disorders, 2020
Background Hypertension (HTN) is a ubiquitous risk factor for numerous non-communicable diseases, including cardiovascular disease and stroke. There are currently no wholly effective pharmacological therapies for subjects with HTN.
Sadegh Jafarnejad, Hamed Mirzaei, Cain C. T. Clark, Mohsen Taghizadeh, Armin Ebrahimzadeh   +4 more
doaj   +4 more sources

Blood substitutes: possibilities with nanotechnology. [PDF]

Indian J Hematol Blood Transfus, 2014
Alam F, Yadav N, Ahmad M, Shadan M.
europepmc   +2 more sources

Blood substitutes: why haven't we been more successful? [PDF]

Trends Biotechnol, 2014
Alayash AI.
europepmc   +2 more sources

Effects of potassium-enriched salt substitutes on blood pressure in Iranian hypertensive patients: the protocol for a randomised, double-blind controlled trial [PDF]

BMJ Open
Introduction Potassium-enriched salt substitutes have favourable effects on blood pressure, but it has not been tested in Iran. The present protocol is a double-blinded, randomised-controlled trial designed to investigate the effects of potassium ...
Mostafa Qorbani, Elnaz Daneshzad, Behnaz Ghoreshi, Seyed Esmaeil Hatami, Sahar Sobhani, Nami-Mohammadin Khonsari, Ehsan Shahrestanaki, Mojgan Pezeshki, Zahra Farhad Kiaee, Omid Assar   +9 more
doaj   +2 more sources

Blood substitutes: evolution from noncarrying to oxygen- and gas-carrying fluids. [PDF]

ASAIO J, 2013
Cabrales P, Intaglietta M.
europepmc   +2 more sources

Nanobiotechnology and blood substitutes

Asian Journal of Transfusion Science, 2011
Saini Rajiv, Saini Santosh, Sharma Sugandha   +2 more
doaj   +2 more sources

Optimization of Hemoglobin Encapsulation within PLGA Nanoparticles and Their Investigation as Potential Oxygen Carriers

Pharmaceutics, 2021
Hemoglobin (Hb)-based oxygen carriers (HBOCs) display the excellent oxygen-carrying properties of red blood cells, while overcoming some of the limitations of donor blood.
Clara Coll-Satue, Michelle Maria Theresia Jansman, Peter Waaben Thulstrup, Leticia Hosta-Rigau   +3 more
doaj   +1 more source

Hemoglobin‐Related Biomaterials and their Applications

Advanced NanoBiomed Research, 2023
Hemoglobin (Hb) is a physiological oxygen‐transport metalloprotein present in the red blood cells. With the in‐depth study, many functions of Hb are developed, and kinds of Hb‐related biomaterials are applied for biomedical therapeutics in the past ...
Shaobing Li, Wei Sun, Min Ouyang, Bo Yu, Yan Chen, Yupeng Wang, Dongfang Zhou   +6 more
doaj   +1 more source

Research of storable and ready-to-use artificial red blood cells (hemoglobin vesicles) for emergency medicine and other clinical applications

Frontiers in Medical Technology, 2022
Hemoglobin (Hb) is the most abundant protein in blood, with concentration of about 12–15 g/dl. The highly concentrated Hb solution (35 g/dl) is compartmentalized in red blood cells (RBCs).
Hiromi Sakai, Tomoko Kure, Kazuaki Taguchi, Hiroshi Azuma   +3 more
doaj   +1 more source

Facing Trauma and Surgical Emergency in Space: Hemorrhagic Shock

Frontiers in Bioengineering and Biotechnology, 2022
Although the risk of trauma in space is low, unpredictable events can occur that may require surgical treatment. Hemorrhage can be a life-threatening condition while traveling to another planet and after landing on it. These exploration missions call for
D. Pantalone, O. Chiara, S. Henry, S. Cimbanassi, S. Gupta, T. Scalea   +5 more
doaj   +1 more source